期刊
CLINICAL IMMUNOLOGY
卷 245, 期 -, 页码 -出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.clim.2022.109143
关键词
Juvenile idiopathic arthritis (JIA); Management of JIA; Consensus guidelines; Multidisciplinary care
类别
资金
- Affibody
- Panoptes
- Ursapharm
- Novartis
- Novartis foundation
- Pfizer (IIT)
- MBS (IIT)
This article summarizes the recent update of the interdisciplinary, consensus-based German guidelines on the management of juvenile idiopathic arthritis (JIA). Through multi-disciplinary and consensus participation, therapeutic principles and recommendations were proposed, providing physicians with evidence-based tailored treatment approaches.
Background: New therapeutic strategies for juvenile idiopathic arthritis (JIA) have evolved within the past ten years, and as a result, an update of the 2011 recommendations of the German management guidelines was initiated.Methods: A systemic literature review was performed, overarching principles were proposed and pre-selected via an online survey followed by two multidisciplinary consensus conferences. Pharmacological and non -pharmacological treatments were discussed, statements were proposed and ultimately agreed upon by nomi-nal group technique (NGT).Results: 12 overarching therapeutic principles, as well as 9 recommendations on pharmacological and 5 on non -pharmacological treatments for JIA were agreed upon.Conclusion: This report summarizes the recent update of the interdisciplinary, consensus-based German guide-lines on the management of JIA. The multi-and interdisciplinary participation of all caregivers was central for this patient-focused update. With these guidelines, physicians can choose an evidence-based approach, which allows better tailored treatment in this vulnerable cohort of children and adolescents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据